Rs7442295

From SNPedia

Jump to: navigation, search
is asnp
is mentioned by
dbSNPrs7442295
hapmaprs7442295
hgdprs7442295
ensemblrs7442295
gopubmedrs7442295
scholarrs7442295
googlers7442295
pharmgkbrs7442295
hgvbaseg2prs7442295
medrefsnprs7442295
23andMers7442295
SNP Nexus

GeneSLC2A9
Chromosome4
Orientationplus
Position9575477
GenotypeEffect
rs7442295(A;A)~4x higher risk for hyperuracemia
rs7442295(A;G)~2x higher risk for hyperuracemia
rs7442295(G;G)normal


Genotypes Magnitude Summary
Rs7442295(A;A) 22 ~4x higher risk for hyperuracemia
Rs7442295(A;G) ~2x higher risk for hyperuracemia
Rs7442295(G;G) normal

rs7442295 is a SNP in the SLC2A9 gene; this gene encodes a glucose transporter.

Based on an initial study of 1900+ hypertensive Caucasian Europeans, the more common allele rs7442295(A) allele was associated with higher serum urate and hyperuracemia (defined as urate >0.4 mMol/l), with a reported odds ratio of 1.89 (CI: 1.36-2.61, p=5 x 10-5). This was also seen in an associated meta-analysis conducted with a broadly representative population and using a surrogate SNP, rs6449213, which is in fairly tight linkage (r2=0.88) with rs7442295.[PMID 18179892]

To put it another way, 79% of white Europeans carry one or two alleles leading to higher serum urate levels. Each copy leads to an average increase of 0.02mMol/l, and, an ~doubling of risk for hyperuracemia.[PMID 18179892]

? (A;A) (A;G) (G;G)
GWAS
SNP rs7442295
PubMedID [PMID 18179892]
Condition Serum urate
Gene SLC2A9,WDR1
Risk Allele A
pValue 2.00E-015
OR 0.02
95% CI 0.02-0.03) mMol/L highe


GWAS snp
PMID [PMID 18327256]
Trait Serum urate
Title SLC2A9 influences uric acid concentrations with pronounced sex-specific effects
Risk Allele C
P-val 3.0000000000000001E-70
Odds Ratio 0.35 [NR] mg/dl decrease in uric acid
Related to HYPOURICEMIA, RENAL, 2; RHUC2 according to omim 612076. See also


Related to SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER according to omim 606142. See also


PharmGKBPA162356758
Name
AnnotationGWAS Results: SLC2A9 influences uric acid concentrations with pronounced sex-specific effects (Initial Sample Size: 1,644 individuals; Replication Sample Size: 9,947 individuals; Risk Allele: rs7442295-C).
GeneSLC2A9
Featue
EvidencePubMed ID:18327256; Web Resource:http://www.genome.gov/gwastudies/
Drugs
DiseasesCardiovascular Diseases
Curation LevelNon-Curated